Ultragenyx Pharmaceutical Inc. buy Truist Financial Co.
Start price
05.11.25
/
50%
€27.80
Target price
05.11.26
€78.31
Performance (%)
-32.73%
Price
13.03.26
€19.00
Summary
This prediction is currently active. Massive losses of -32.73% have been the result for the BUY prediction by Truist_Financial_Co_. This prediction currently runs until 05.11.26. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 4.396% | 4.396% |
| iShares Core DAX® | -1,10 % | -6,08 % |
| iShares Nasdaq 100 | 0,33 % | 2,33 % |
| iShares Nikkei 225® | -1,08 % | -7,99 % |
| iShares S&P 500 | -0,06 % | 0,88 % |
Comments by Truist_Financial_Co_ for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical (NASDAQ:RARE) had its price target lowered by analysts at Truist Financial Corporation from $100.00 to $90.00. They now have a "buy" rating on the stock.
Ratings data for RARE provided by MarketBeat